INTEGRA LIFESCIENCES HOLDINGS CORP - 10-Q Filing
Integra Lifesciences reports Q3 2026 financial results including segment performance for Specialty Surgery and Tissue Reconstruction.
Tickers: $IART
Read the full article at SEC EDGAR
Part of the story HEXCEL CORP /DE/ - 10-Q Filing (6 articles)